Genmab — December 2014
-
-
De tester i metastatic cancers
-
Vi lejer i høje luftlag nu. Nogle som er ved at få højdeskræk ?
-
haha

-
Bare det ikke er et dead cat bounce så
-
Lymphomahub har Ofatumumab Maintenance studiet med på listen over mest interessante orale præsentationer på ASH. (De interesserer sig ikke for myelomatose) http://www.lymphomahub.com/features/key-abstracts-from-the-ash-2014-annual-general-meeting
-
I like

-
US markerer aktien ned inden luk. Det er standard. BlueCrest gør dette hver dag for tiden
-
Man bør sælge kl. 15.00
og genkøbe og kl. 16.59 hver dag hvis man havde nosser til det
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind